Tranexamic Acid
SpecWhite TA topical applications prevent the binding of plasminogen to keratinocytes, which ultimately results in less free arachidonic acids and a diminished ability to produce PGs, and this decreases melanocyte tyrosinase activity.
Dosage:
0.5-3.0
